Soc. Generale Put 40 OMV 20.12.20.../ DE000SY1ECC1 /
15/11/2024 16:51:15 | Diferencia-0.020 | Bid17:35:18 | Ask17:35:18 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.190EUR | -9.52% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
OMV AG | 40.00 EUR | 20/12/2024 | Put |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- Primera página
- Atrás
- 1
- 2
- Siguiente
- Última página